| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.62B | -59.4% | +12.6% |
| Cost of Revenue | $1.64B | -43.9% | +5.0% |
| R&D Expense | $351.0M | -6.4% | +0.9% |
| SG&A Expense | $725.0M | -37.3% | +8.0% |
| Interest Expense | $134.0M | +157.7% | +103.0% |
| Pre-tax Income | -$370.0M | -120.5% | +41.5% |
| Income Tax | -$62.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.51B | +21.5% | +3.6% |
| Short-term Investments | $77.0M | +1.3% | +6.9% |
| Accounts Receivable | $5.05B | -15.3% | +18.5% |
| Inventory | $5.31B | +23.0% | -6.4% |
| Current Assets | $16.44B | +2.7% | +5.0% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$969.0M | — | — |
| Investing Cash Flow | -$355.0M | — | — |
| Financing Cash Flow | $554.0M | — | — |
| -114.7% |
| +45.6% |
| Net Income | -$320.0M | -124.4% | +38.9% |
| EPS (Basic) | -$0.47 | -124.5% | +38.2% |
| EPS (Diluted) | -$0.47 | -124.5% | +38.2% |
| $42.20B |
| +1.1% |
| +0.7% |
| Current Liabilities | $10.42B | +9.5% | -0.0% |
| Long-term Debt | $1.69B | +0.1% | -14.5% |
| Stockholders' Equity | $25.22B | -2.7% | +1.9% |